Prestige Consumer Healthcare Inc (PBH)

Currency in USD
64.57
-0.30(-0.46%)
Real-time Data·
PBH Scorecard
Full Analysis
Management has been aggressively buying back shares
PBH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
64.4865.81
52 wk Range
62.9590.04
Key Statistics
Prev. Close
64.87
Open
65.11
Day's Range
64.48-65.81
52 wk Range
62.95-90.04
Volume
279.37K
Average Volume (3m)
430.42K
1-Year Change
-5.37%
Book Value / Share
37.69
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PBH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
82.80
Upside
+28.23%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Prestige Consumer Healthcare Inc Company Profile

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under Debrox brand name. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

Employees
600

Prestige Consumer Healthcare Inc Earnings Call Summary for Q4/2024

  • Prestige Consumer Healthcare expects $830M revenue gain for 2025, with $500M organic growth and 2-3% volume growth in Canada
  • Four recent acquisitions and a new Tennessee facility set to boost product offerings and production capacity significantly
  • Strong financial health with EBITDA of $361.26M and 55.9% gross profit margin; stock near 52-week high at $84.36
  • U.S. growth pipeline strong with $1.4B potential opportunities; 2027 targets reiterated despite paused dividend increases
  • CEO confident in growth trajectory; CFO addresses financial structure concerns amid increased inventory days and CapEx requirements
Last Updated: 21/03/2025, 19:36
Read Full Transcript

Compare PBH to Peers and Sector

Metrics to compare
PBH
Peers
Sector
Relationship
P/E Ratio
15.0x5.7x−0.6x
PEG Ratio
3.590.170.00
Price/Book
1.7x1.2x2.6x
Price / LTM Sales
2.9x1.7x3.3x
Upside (Analyst Target)
23.3%181.0%39.1%
Fair Value Upside
Unlock23.1%4.5%Unlock

Analyst Ratings

4 Buy
2 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 82.80
(+28.23% Upside)

Earnings

Latest Release
Aug 07, 2025
EPS / Forecast
0.95 / 1.00
Revenue / Forecast
249.53M / 261.00M
EPS Revisions
Last 90 days

PBH Income Statement

People Also Watch

54.69
HAE
+2.96%
193.14
IQV
+0.31%
86.38
MMSI
+0.25%
173.51
MOH
+2.58%
149.38
CAH
-0.23%

FAQ

What Stock Exchange Does Prestige Consumer Health Trade On?

Prestige Consumer Health is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Prestige Consumer Health?

The stock symbol for Prestige Consumer Health is "PBH."

What Is the Prestige Consumer Health Market Cap?

As of today, Prestige Consumer Health market cap is 3.19B.

What Is Prestige Consumer Health's Earnings Per Share (TTM)?

The Prestige Consumer Health EPS (TTM) is 4.29.

When Is the Next Prestige Consumer Health Earnings Date?

Prestige Consumer Health will release its next earnings report on 29 Oct 2025.

From a Technical Analysis Perspective, Is PBH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Prestige Consumer Health Stock Split?

Prestige Consumer Health has split 0 times.

How Many Employees Does Prestige Consumer Health Have?

Prestige Consumer Health has 600 employees.

What is the current trading status of Prestige Consumer Health (PBH)?

As of 19 Aug 2025, Prestige Consumer Health (PBH) is trading at a price of 64.57, with a previous close of 64.87. The stock has fluctuated within a day range of 64.48 to 65.81, while its 52-week range spans from 62.95 to 90.04.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.